News & Updates
Filter by Specialty:
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) albiglutide results in fewer cardiovascular events, irrespective of sodium-glucose cotransporter-2 (SGLT2) inhibitor use, among patients with type 2 diabetes (T2D) and cardiovascular disease, according to the post hoc analysis of Harmony Outcomes*.
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
08 Aug 2023
Large cohort study on diabetes launched
The Seremban Diabetes (SeDia) Cohort Study, the first large-scale diabetes study of its kind in Malaysia has been launched by the Ministry of Health Malaysia (MOH) and International Medical University (IMU).
Large cohort study on diabetes launched
07 Aug 2023
Glucocorticoid discontinuation may prevent infection in older RA patients
For older patients with rheumatoid arthritis (RA) who are receiving glucocorticoids (GCs), stopping its use lowers the incidence of infection, according to a study.
Glucocorticoid discontinuation may prevent infection in older RA patients
05 Aug 2023
Probiotic supplementation in pregnant women with obesity of little benefit to mothers, babies
In pregnant women with obesity, supplementation with multi-strain probiotics does not appear to have favourable effects on the metabolic or inflammatory biomarkers in mothers and on the body composition of their offspring, according to a study.